Forget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France

Similar documents
Angiosome revascularization strategies in real world practice: how much difference does it make?

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

Does heparin impregnated graft improve patency and reduce the cost of lower limb bypass? The REPLACE trial Y. Gouëffic, MD, PhD

Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound

Endovascular Should Be Considered First Line Therapy

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

Interventional Treatment First for CLI

Angiosome concept myth or truth? Does it make a real difference in real world cases?

Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Disclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium

Wound and surgery-guided revascularization & flow-guided surgery: the multidisciplinary approach to limb salvage

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Specificities for infrapopliteal stents

Evaluating the economic value of 5F systems for outpatients

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD

Clinical Approach to CLI and Related Diagnostics: What You Need to Know

The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA

Preliminary 6-month results of VMI-CFA trial

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD

I am no good at debates!

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data)

SPINACH Making Limb Salvage Salad from Spinach alone

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia

First time data release: Initial experience with the temporary Spur Stent System: DEEPER Trial first-in-man results Jihad A. Mustapha, MD, FACC,

Are DES and DEB worth the cost in BTK interventions?

When is below-the-ankle angioplasty indicated and how to introduce it into your practice. Roberto Ferraresi. Peripheral Interventional Unit

2D Perfusion imaging to assess the result of BTK interventions. Shinya Sasaki, M.D. Saka General Hospital Miyagi, JAPAN

Francisco Acín, César Varela, Ignacio López de Maturana, Joaquín de Haro, Silvia Bleda, and Javier Rodriguez-Padilla

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study -

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report

6/6/2016. Pedal Loop Reconstruction: A Crash Course in 60 minutes. Pedal-Plantar Anatomy. Anand Prasad, MD, FACC, FSCAI, RPVI.

Practical Point in Holistic Diabetic Foot Care 3 March 2016

Endovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial

UC SF. Disclosures. Vascular Assessment of the Diabetic Foot. What are the best predictors of wound healing? None. Non-Invasive Vascular Studies

Use of Laser In BTK Disease (CLI)

3-year results of the OLIVE registry:

Fluorescent Angiography: Practical uses in the Clinical Setting

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis

Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization

Device Evolution. Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance. Where Do We Stand? 4/18/2015

Surgical Bypass vs. Zilver PTX stent for long SFA lesions : Interim results of the ZilverPass Trial

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts

Objective assessment of CLI patients Hemodynamic parameters

Surgical Bypass or. Zilver PTX. 12 months preliminary data. LINC 2016, Leipzig. Marc Bosiers, MD. Marc Bosiers Koen Deloose Joren Callaert

A randomized comparison of endovascular versus surgery treatment of common femoral artery disease: Results from the TECCO trial

Imaging Strategy For Claudication

Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department "Careggi " University Hospital Florence - Italy

The essentials for BTK procedures: wires, balloons, what else

Recent Advances in Peripheral Salvage

THERE IS NO PROOF FOR THE ANGIOSOME CONCEPT

Will it heal? How to assess the probability of wound healing

DEB in Periphery: What we Know Till Now

LIMB SALVAGE IN THE DIABETIC PATIENT

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria

Present & future of below the knee stenting

The LIMBO trial: a RCT investigating adventitial dexamethasone infusion to prevent restenosis in BTK arteries utilizing a novel angiographic endpoint

DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes

Do we really need a stent in long SFA lesions? No: DEB is the answer

Is stenting a safe and durable option in the common femoral artery?

Practical Point in Diabetic Foot Care 3-4 July 2017

Critical limb ischemia due to an occlusion of an aorto-biiliac prothesis step by step case presentation and decision making

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge

Do the newest grafts achieve comparable results to saphenous vein bypass? THE HEPARIN-BONDED eptfe GRAFT. C. Pratesi

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan

CLI Treatment Using Long and Scoring Balloons

12-month Outcomes of Post Dilatation in the IN.PACT Global CTO Cohort. Gunnar Tepe, MD RodMed Clinic Rosenheim Rosenheim, Germany

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

Konstantinos Katsanos, MSc, MD, PhD, EBIR. Consultant Interventional Radiologist Guy's and St.Thomas' Hospitals, NHS Foundation Trust

BEST-CLI Trial Study Concept and Current Status

BIOLUX P-III Passeo-18 Lux All-comers Registry: 12-month Results for the All-Comers Cohort

LUTONIX DCB in BTK Update on the BTK clinical program & single center experience

Clinical Data Update for Drug Coated Balloons (DCB) Seung-Whan Lee, MD, PhD

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia

The latest generation DEB

How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia?

Peripheral Arterial Disease: the growing role of endovascular management

Peripheral arterial disease for primary care Ed Aboian, MD

Arterial Studies And The Diabetic Foot Patient

Clinical use and safety of the Lutonix DCB for the treatment of BTK: interim data from a prospective registry

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA

No Option CLI- A Rising Epidemic and an Overview of Solutions

The Burden of CLI and Crosser Catheter Recanalization Strategies

Perfusion Assessment in Chronic Wounds

Hydrodynamic boost: a novel re-entry technique in distal BTK vessel: when and how to do it

Directional Atherectomy and Gender Outcomes in DEFINTIVE LE

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?

Due to Perimed s commitment to continuous improvement of our products, all specifications are subject to change without notice.

Disclosures. Carotid artery stenting. Surveillance after Endovascular Intervention: When to Re-Intervene and What s the Evidence

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines

COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions. Dierk Scheinert

Transcription:

Forget about the angiosome theories Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France

Disclosure of Interest Research grants /Consulting/Honoraria for - Abbott - Bard - Boston Sc - Cook - Hexacath - Medtronic - Spectranetics - Terumo - WL Gore

Patient history Male, 72 y Symptomatology - CLI of the left foot (Rutherford 5) Medical history - Dislipidemia, HTA, active smoking - Peripheral arterial disease - Coronaropathy Duplex scan - Diffuse lesions of femoropopliteal segment Angiography - Femoropoplpiteal thrombosis - No run off

Transmetatarsal amputation of the 1st toe without revascularization

Angiogram

Peroneal artery Posterior tibial artery Angiosome based revascularization Angiosome is an anatomic unit of tissue fed by a source artery and drained by specific veins.

Biancari, Eur J Vasc Endovasc Surg, 2014

A prospective study to evaluate the angiosome concept on the level of microcirculation during BTK interventions. - 30 patients with isolated tibial angioplasty - Macrocirculation was evaluated by measurement of ABI. - Microcirculation was evaluated by a combined method of laser Doppler flowmetry and tissue spectrometry - Measuring points were located over different angiosomes of the index foot; a control probe was placed on the contralateral leg. Conclusions: There is a significant overall improvement in tissue perfusion of the foot immediately after tibial angioplasty. The effect shown was found to be global and was not restricted to certain borders, such as defined by angiosomes. Rother, J Vasc Surg 2016

To investigate factors in patients with CLI and isolated infrapopliteal lesions that adversely affect outcomes of endovascular therapy with or without angiosome-oriented revascularization. - Retrospective multicenter study - 718 consecutive CLI patients - 75% diabetics, 68% hemodialysis, 24% Rutherford 6 - Primary outcome was freedom from MALE - Comparison between direct and indirect angiosome revascularization Conclusion: Limb prognosis was equivalent for direct and indirect endovascular revascularization except in the presence of both diabetes and wound infection. Iida, Eur J Vasc Endovasc Surg, 2013

Wounds were not located only in one angiosome but that, more likely, they affect several angiosomes. In 33% of the patients, there was only one crural artery suitable for revascularization. Indirect revascularization because: - Technical failure to realize direct revascularization (50%) - No attempt because of a long lesion (30%) - No explanation (20%) => vessel providing easier revascularization was selected. Spillerova, Ann Vasc Surg, 2016.

Femoropopliteal recanalization

Long femoropopliteal stenting

Fibullar artery recanalization

Final angiogram

1-month later

Message to take home We forget the angiosome theory: In patients without diabetes (Iida, Eur J Vasc Endovasc Surg, 2013) (In patient without renal failure) Tissue perfusion of the foot immediately after tibial angioplasty is improved globally and is not restricted to certain borders, such as defined by angiosomes (Rother, J Vasc Surg 2016) Several angiosomes are affected in 76% cases (Spillerova, Ann Vasc Surg, 2016) We select the easier vessel to revascularize (time consuming, costly, technical success)

Angio 2D for an intra operative assessment 2D perfusion angiography can help to determine an endpoint for revascularization. Standard digital subtraction angiography 2D perfusion images are obtained by automatic reconstruction with postprocessing software on a dedicated workstation (Philips Medical Systems). The reconstructed images can be evaluated for arrival time, time to peak, wash-in rate, width, area under the curve, and mean transit time. Comparison of the density before and after the interventional procedure is subsequently performed. J Van Den Berg, Endovascular today, 2016